Discover more with Renasight™
- NKF and KDIGO recommend genetic testing for patients with kidney disease.1,2
- Renasight™ is a comprehensive kidney panel with 385 genes custom-designed for nephrology
- Identify rare and common inherited conditions associated with chronic kidney disease (CKD), nephrolithiasis, and electrolyte disorders— including PKD1 and the APOL1 risk allele
- Includes conditions associated with pediatric and adult forms of CKD
Meaningful utility for you and your patients
RenaCARE, a large-scale multi-site prospective study of genetic testing in CKD, demonstrates the diagnostic and clinical utility of Renasight™1
Backed by societies, proven by research
The National Kidney Foundation (NKF) and Kidney Disease Improving Global Outcomes (KDIGO) now recommend genetic testing for the majority of patients with kidney disease.1,2 These recommendations highlight the crucial role of genetic testing and encourage broad use in Nephrology care.
See additional published support for genetic testing
Enable improved diagnoses and patient care
Determine the underlying cause of disease where clinical features alone fell short or were previously unknown.
Impact treatment path by using test results to inform more tailored interventions.
Detailed the subtype of a CKD diagnosis.
Educate family members who may also be at risk for kidney disease.
Eligibility for appropriate clinical trials that may provide advanced treatments and interventions.
The Renasight™ Difference
Renasight™ is the leading renal generic test. We are focused on making genetic testing comprehensive, convenient, and accessible.
Comprehensive
Renasight™ is a comprehensive kidney panel with 385 genes custom-designed for nephrology.
- Selected by genetic experts to provide actionable information
Convenient
Natera provides support for providers and patients at every step.
- Seamless remote testing services for providers and at home sample collection for patients (saliva or mobile blood draw).
- Complimentary information sessions with board-certified genetic counselors.
- Clear, actionable reports, served with time-saving tools and access to expert guidance.
Accessible
We are committed to making testing as affordable as possible
- Most patients have little-to-no out of pocket cost
- In the rare situation where the cost is above $149, we will attempt to reach out to the patient to determine if they qualify for our financial assistance programs.
Explore Case Studies
Explore and submit real-world case studies showcasing the impact of Renasight™. See how industry leaders are improving diagnoses and patient care in nephrology with Renasight™
Support for you and your patients at every step
Access to complimentary renal genetic experts and resources
Natera’s team of renal genetic counselors are trained and certified to provide the highest level of support to you and your patients
For Providers
- Consult prior to testing to review gene panel and answer questions
- Provide guidance on the Renasight™ test report
- Explain how gene changes can cause genetic conditions
- Inform clinicians when a Variant of Uncertain Significance (VUS) has been reclassified
For Patients
- Pre-test education on the benefits of Renasight™
- Review Renasight™ test results, with post-test summary given to providers to add to patient charts
- Discuss modes of inheritance and recurrence risks of genetic conditions for patients and family members
Request more information about Renasight™
References
1Natera data on file
2Groopman EE, Marasa M, Cameron-Christie S et al. Diagnostic utility of exome sequencing for kidney disease. NEJM. 2018;doi:10.1056.